Showing results (391-400 of 431) with videos related to

Sort By:
Pageof 44
Nature Communications|November 5, 2022
CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapyAbhinav Kaushik, Diane Dunham, Xiaorui Han, et al.
Allergy|March 30, 2021
Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumabMonali Manohar, Diane Dunham, Sheena Gupta, et al.
Nature Immunology|November 4, 2025
Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsivenessXiaorui Han, Valeria Skatova, Artem Mikelov, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2020
Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral ImmunotherapyBenjamin L Wright, Nielsen Q Fernandez-Becker, Neeraja Kambham, et al.
Frontiers in Immunology|December 8, 2018
Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut AllergyBenjamin L Wright, Nielsen Q Fernandez-Becker, Neeraja Kambham, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 22, 2024
Skin as the target for allergy prevention and treatmentAndreina Marques-Mejias, Irene Bartha, Christina E Ciaccio, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.
Frontiers in Immunology|November 7, 2025
Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy studySayantani B Sindher, Andrea Fernandes, Monali Manohar, et al.
Allergy|December 14, 2024
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II StudySayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 9, 2026
Biologics and Novel Therapeutics in Food AllergyBrent Anderson, Claire Pascal, M Gohazrua K Butler, et al.
Pageof 44